About
BioSymetrics is a phenomics-driven company that translates complex human disease biology into discoveries using AI and in vivo validation to identify higher-confidence targets and precision medicines. Their platform connects disease phenotype and genotype data, leverages machine learning predictions, and couples this with high-content in vivo validation for speed and confidence in translation. They focus on advancing target discovery programs in neurological, cardiometabolic, and rare diseases, partnering with global pharmaceutical companies, hospitals, and research organizations.
Tags
Total Employees
13
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BioSymetrics do?
BioSymetrics is a phenomics-driven company that translates complex human disease biology into discoveries using AI and in vivo validation to identify higher-confidence targets and precision medicines. Their platform connects disease phenotype and genotype data, leverages machine learning predictions, and couples this with high-content in vivo validation for speed and confidence in translation. They focus on advancing target discovery programs in neurological, cardiometabolic, and rare diseases,…
How much funding has BioSymetrics raised?
BioSymetrics has raised a total of $7M in funding. The most recent round on record is Seed.
When was BioSymetrics founded?
BioSymetrics was founded in 2017.
How many employees does BioSymetrics have?
BioSymetrics has approximately 13 people on record.
What is BioSymetrics's current status?
BioSymetrics's current operating status is: Acquired/merged.